Across TCGA pan-cancer cohorts, RNU6-205P RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated RNU6-205P data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RNU6-205P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-205P expression acts as an unfavorable survival marker.

STAD, HNSC, and KIRC are the cancer types where RNU6-205P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	All	0.382	0.666	.003	72	view →
HNSC	DFS	Tertile	All	0.163	0.696	.007	72	view →
KIRC	DFS	Tertile	II,III,IV	0.002	0.762	<.001	36	view →
BLCA	DFS	Tertile	All	0.185	0.627	.005	36	view →
ESCA	OS	Tertile	All	0.198	0.872	.003	36	view →
KIRP	DFS	Tertile	All	0.277	0.867	.004	18	view →
SARC	OS	Tertile	All	0.162	0.767	.002	18	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

Exploration

Same gene, other analysis: RNU6-205P tumor-vs-normal RNA expression · all RNU6-205P data types